How Bayer lured a biotech away from an IPO and into a buyout
Bio Pharma Dive
AUGUST 4, 2021
Vividion Therapeutics was headed toward an IPO earlier this year, but a company executive said Bayer’s $1.5B offer ended up being a more attractive option.
Sat.Jul 31, 2021 - Fri.Aug 06, 2021
360 
DTC Study: Marketers misaligned with online health seeker needs
World of DTC Marketing
AUGUST 4, 2021
SUMMARY: People are going online more and more to sarch for health information after seeing a DTC pharma TV spot. Pharma websites are not consdiered a top resource for infromation on new products. Cost is not that big of an issue for people who have health insurance. It’s more about weighing the benefit against the potential side effects. TV spots are the number one way people learn about new pharma products.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
In the News: July 2021 Regulatory and Development Updates
Camargo
AUGUST 5, 2021
Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Approval of the Month: Repurposed Transplant Drug Approved Based Only on Real-World Evidence. In July, Astellas Pharma US received FDA approval for the use of Prograf (tacrolimus) capsules, injection, and oral suspension for the prevention of lung transplant rejection.
UK trial to assess Sativex for the treatment of ‘aggressive’ brain tumours
Pharma Times
AUGUST 4, 2021
Sativex is a complex botanical formulation that contains the principal cannabinoids THC and CBD
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
HHS watchdog to review FDA accelerated approval process after Aduhelm controversy
Bio Pharma Dive
AUGUST 4, 2021
Acting FDA head Janet Woodcock asked for an investigation of the agency's decision to approve Biogen's Alzheimer's drug, but the inspector general's planned review appears to be more broadly aimed.
Health literacy is a huge problem
World of DTC Marketing
AUGUST 6, 2021
SUMMARY: The states struggling the most with covid-19 infections also have the least healthy populations. About two out of five American adults are obese, according to the CDC. Mostly because they don’t understand how what they eat effects their health. Only 23% of people get enough exercise and only one in ten eats enough fruit and vegetables, says the CDC.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Artificial intelligence stands to ‘revolutionize’ research: Bioclinica
Outsourcing Pharma
AUGUST 5, 2021
A leader from the clinical research tech specialist explains how the use of AI is increasing in the field and outlines the many ways it could SOMETHING.
AstraZeneca wins first FDA approval for systemic lupus drug in a decade
Bio Pharma Dive
AUGUST 2, 2021
The regulator cleared Saphnelo despite mixed clinical trial data, giving patients another option after the recent OK for a drug aimed at the autoimmune disease's severe side effects.
Even on social media “listen to the doctor”
World of DTC Marketing
JULY 31, 2021
SUMMARY : People are anxious because of the resurgence of COVID. Unfortunately, there is a lot of false and bad information online. To get accurate information, follow one of the many physicians online. They can provide answers based on science and their experience. The amount of critical health information online is an enormous problem. The media still hasn’t, for example, differentiated between testing positive for COVID and getting sick from COVID.
SMA Awareness Month: How pharma and digital solutions can improve patient care
pharmaphorum
AUGUST 4, 2021
Spinal Muscular Atrophy (SMA) is a rare disease affecting the motor nerve cells in the spinal cord. It’s a debilitating condition that affects 1 per 8,000 to 10,000 people worldwide , impacting their ability to walk, eat, and breathe. SMA Type 1 represents an estimated 50% of all cases, for which life expectancy is less than 18 months without treatment. .
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
F.D.A. Aims to Give Final Approval to Pfizer Vaccine by Early Next Month
NY Times
AUGUST 3, 2021
The Food and Drug Administration’s move is expected to kick off more vaccination mandates for hospital workers, college students and federal troops.
FDA allows Novartis gene therapy trials to resume after nearly two year pause
Bio Pharma Dive
AUGUST 3, 2021
After reviewing animal study data submitted by the Swiss pharma, the FDA cleared spinal injections of Zolgensma for study in older patients with SMA.
Corporate politics and eMarketing: Mismatched
World of DTC Marketing
AUGUST 2, 2021
SUMMARY: The biggest barrier to great healthcare marketing is corporate politics. As more companies merge or are bought out big bureaucratic processes run counter to what online marketing is all about. Those people who are willing to disrupt pharma cultures will have a great career but it takes time, effort, and empathy for patients to make changes.
Positive Phase III results for Valneva’s chikungunya vaccine
Pharma Times
AUGUST 5, 2021
Neutralising antibody titers were observed in 98.
Could DNA-based COVID-19 vaccine offer variant-busting booster shot?
BioPharma Reporter
AUGUST 2, 2021
With Scancell taking its DNA-based COVID-19 vaccine tech into clinical trials this year, it is already focusing its attention on the techâs potential to be used as a needle-free booster shot to address Variants of Concern.
Startup EQRx to take drug price mission public through $1.8B SPAC deal
Bio Pharma Dive
AUGUST 6, 2021
A merger with a blank-check company backed by Casdin Capital will greatly expand the resources available to EQRx, which aims to develop competitors to existing drugs and sell them at "radically lower" prices.
A Pivotal Moment for CRISPR in the Gene Editing Journey
BioSpace
AUGUST 3, 2021
With this milestone, the field is now wide open for the next in vivo CRISPR success, and Editas is hoping that it will be in the ocular disease space.
AZ’s Saphnelo scores US approval for systemic lupus erythematosus
Pharma Times
AUGUST 2, 2021
Saphnelo is the first type I interferon receptor agonist to receive regulatory approval
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical industry must fix broken supply chain: Phlow
Outsourcing Pharma
AUGUST 3, 2021
A leader from the company says to ensure medicines keep reaching the patients that need them, the industry must revamp outdated technologies and techniques.
Gilead's Kite bets on early-stage biotech to advance allogeneic cell therapies
Bio Pharma Dive
AUGUST 5, 2021
Appia Bio, which launched with over $50 million in Series A funding earlier this year, will provide preclinical research for two CAR-iNKT candidates, which Kite will pick up should they advance past early clinical testing.
Find Talent in the Pharmaceutical Industry: A Step-By-Step Guide to Xtalks Job Search
XTalks
AUGUST 4, 2021
The search to find talent in the life sciences isn’t always an easy pursuit. It requires ongoing strategies for attracting, retaining and developing the right candidates. Talent acquisition and employment practices are constantly changing in the pharma industry. This is why employers must stay up to date with the latest hiring trends. Popular online job platforms (such as Indeed, ZipRecruiter and other broader job posting websites) are optimized for unemployed job seekers.
NICE pens two-year collaboration with the Academic Health Science Network
Pharma Times
AUGUST 5, 2021
Agreement will support use of the 'best evidence-based healthcare' in the NHS
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Psychedelics research institute launches in Australia
Outsourcing Pharma
AUGUST 3, 2021
The Psychae Institute, established by a global team of scientists, will conduct pre-clinical and clinical research around psychedelic medicine development.
Regeneron drug extends survival in lung cancer trial, lifting company's hopes in field
Bio Pharma Dive
AUGUST 5, 2021
The biotech also reported second quarter earnings on Thursday that widely surpassed Wall Street expectations.
Evaluating methods targeting Protein-Protein Interactions
pharmaphorum
AUGUST 5, 2021
Protein-protein interactions (PPIs) are becoming increasingly relevant in the pathology of many diseases, including cancer. The issue, however, is developing an effective way of targeting them. . The latest advancements in methods targeting PPIs are designed to overcome the challenges limiting the conventional methods. Targeting PPIs offers another potential therapeutic target for diseases with complex biological profiles.
Long COVID rare in children, KCL study finds
Pharma Times
AUGUST 4, 2021
Less than one in 20 children had symptoms for more than four weeks
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
AdComms – Is FDA Getting Less Advice?
Eye on FDA
AUGUST 4, 2021
As more drugs are being approved, is FDA getting less advice than in the past? FDA maintains a vast network of outside advisors to provide input and counsel to the agency related to decisions on policy as well as product approvals. There are 31 advisory committees on matters ranging from food to medical devices to pediatric care. Within those focused on human drugs , there are 17 committees organized under therapeutic categories (Arthritis, Cardiovascular and Renal, Gastrointestinal, e.g.).
Data is becoming the healthcare ecosystem entry fee
Bio Pharma Dive
AUGUST 2, 2021
Biopharmaceutical companies have an opportunity to work alongside new healthcare ecosystem entrants for mutual benefit and better customer value.
Treg cell therapy showing promise in ALS trials: Coya Therapeutics
BioPharma Reporter
AUGUST 2, 2021
According to the neurodegenerative-disease-focused biotechnology firm, their research could bring hope to patients with amyotrophic lateral sclerosis.
BMS withdraws Istodax as a treatment for peripheral T-cell lymphoma
Pharma Times
AUGUST 4, 2021
Phase III trials did not demonstrate sufficient clinical benefit.
Let's personalize your content